Additionally, genetic analyses of GBM patient samples have found that a large percentage of GBM has deregulated signaling through the PTEN-PI3K-Akt-mTORC1 axis, which is often due to mutations in the PTEN tumor suppressor [102]. The gene discussed is AKT1; the disease is glioblastoma.